Gabriel Peixoto

Principal Research Associate at Orbital Therapeutics

Gabriel Peixoto has a strong background in research and laboratory work. Gabriel is currently working as a Principal Research Associate at Orbital Therapeutics since February 2023.

Prior to that, Gabriel worked at Ambys Medicines from June 2019 to April 2023. At Ambys Medicines, they held various roles, including Senior Research Associate and Senior Research Associate II. In these positions, Gabriel focused on developing 3D co-cultured cell-therapy models for liver disease rescue, screening for effective cell therapy candidates, and managing cross-functional collaborations with multiple teams. Gabriel also played a key role in training team members and establishing experimental procedure standards.

Before joining Ambys Medicines, Gabriel worked at the University of California, San Francisco (UCSF). From September 2017 to June 2019, they served as a Junior Specialist in the Laboratory of Dr. Julie Sneddon. Prior to that, they worked as a Graduate Research Student in the Laboratory of Dr. Miguel Ramalho-Santos at UCSF from November 2015 to June 2017.

Gabriel's career in research began at San Francisco State University, where they worked as an Undergraduate Student Researcher. Gabriel conducted research in the Laboratory of Dr. Carmen Domingo from May 2014 to June 2015 and also held a position as an Undergraduate Student Researcher from July 2013 to May 2014.

Overall, Gabriel's work experience showcases their expertise in research and laboratory techniques, as well as their ability to manage and collaborate with teams.

Gabriel Peixoto pursued their education starting in 2012 when they enrolled at San Francisco State University. Over the course of three years, from 2012 to 2015, they earned a Bachelor of Science (BS) degree in Cell/Cellular and Molecular Biology. Following this, Gabriel continued their studies at the same university and obtained a Master of Science (MS) degree in Stem Cell Biology. Gabriel completed this program from 2015 to 2017. Additionally, Gabriel sought further education at the University of California, San Francisco to pursue another Master of Science (MS) degree. However, no specified start or end year is provided for this particular program, making their involvement unclear.

Links

Previous companies

Ambys Medicines logo

Org chart